MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers

Yukihiro Akao1, Yoshihito Nakagawa, Tomoki Naoe

  • 1Gifu International Institute of Biotechnology, Gifu 504-0838, Japan. yakao@giib.or.jp

Oncology Reports
|September 14, 2006
PubMed

Insights

MicroRNA (miRNA) 143 and 145 levels are significantly reduced in colon cancer cells, suggesting their potential as tumor markers. Restoring these microRNAs inhibited cancer cell growth, highlighting their role in oncogenesis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression post-transcriptionally.
  • Reduced miRNA expression is observed in various cancers, potentially due to genomic alterations and epigenetic modifications.
  • Enzymatic processing is crucial for miRNA maturation, linking enzyme activity to miRNA levels.

Purpose of the Study:

  • To investigate the expression levels of miRNA 143 and 145 in colon cancer.
  • To determine the functional role of miRNA 143 and 145 in cancer cell growth.
  • To identify potential therapeutic targets and tumor markers related to these miRNAs.

Main Methods:

  • Quantitative analysis of miRNA expression in cancer cell lines.
  • Transfection of precursor miRNAs into colon cancer cells (DLD-1 and SW480).
  • Assessment of cell growth inhibition post-transfection.
  • Identification of miRNA target genes using molecular techniques.

Main Results:

  • Significantly reduced expression of miRNA 143 and 145 was observed in colon cancer cells and other tested cancer types.
  • Transfection with precursor miRNA 143 or 145 suppressed the growth of colon cancer cells.
  • ERK5 was identified as a direct target gene of miRNA 143.
  • Genomic loci for these miRNAs were confirmed, suggesting defects in early processing stages.

Conclusions:

  • miRNA 143 and 145 downregulation is a common event in colon cancer and potentially other malignancies.
  • These miRNAs exhibit tumor-suppressive functions, making them potential therapeutic agents.
  • miRNA 143 and 145 represent promising biomarkers for cancer diagnosis and prognosis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...